This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend CPC

CPC 2022 Programme

Subpage Hero



Personalising Schizophrenia Treatment: The State of the Art

13 May 2022
Personalising Schizophrenia Treatment: The State of the Art







A review of the latest developments in personalising schizophrenia treatment with a spotlight on Long-acting injectable (LAI) antipsychotic medication. Professor Bazire will take a look at some of the newer formulations of LAIs recently approved or in development and how LAIs can be a positive service-user choice. Nicola Greenhalgh will review evidence pointing to better outcomes where LAIs are used earlier in the treatment pathway and thus provide a real alternative to oral treatment.

Stephen Bazire session’s details

The development of antipsychotic long-acting injections - from punishment to patient preference

The session will cover psychosis, its treatment, how and why LAIs can be life-savers, recent and imminent developments in the formulations available and why LAIs have become a positive service user choice.


Nicola Greenhalgh session’s details

What is the place for antipsychotic algorithms?  The Qaapaple conundrum

Long-acting antipsychotic injections have often been held back for people who struggle to adhere to oral antipsychotics, yet evidence points to better outcomes where they are used.  Is it time for us to follow Canada and look at how we can optimise treatment with antipsychotics earlier in treatment?

Speaker honorarium from ROVI.
Non-relevant declarations will be on the first slide.


Professor Stephen Bazire, Honorary Professor, School of Pharmacy, University of East Anglia - Director, Mistura Enterprise
Ms Nicola Greenhalgh, Lead Pharmacist Mental Health - North East london NHS Foundation trust


Lead Education Partner

  • CPPE
  • Morph


Education Partner

  • BOPA
  • BPNG
  • CMHP
  • Health Education England


Education Partner

  • NHS England and NHS Improvement
  • NHS Digital
  • NHSx
  • PTOC
  • GPHC


Education Partner

  • NPPG
  • PCPA
  • PDA
  • Pharmacist Support
  • RPUK
  • SPS


Education Partner

  • Soar Beyond
  • NHCA
  • PrescQIPP
  • Pharmacy Declares
  • GHP and RPS


Media Partner

  • C&D
  • PDA
  • PrescQIPP
  • Scottish Healthcare Review
  • Welsh Healthcare Review
  • NI Healthcare Review
  • Prescriber


Nominated Charity

  • Pharmacist Support


Newsletter Sign Up